These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2117035)

  • 1. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
    Kitajima Y; Hirata H; Kagawa Y; Yaoita H
    J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
    Linke RP; Geisel O; Mann K
    Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambda III subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis.
    Miura K; Shirasawa H
    Am J Clin Pathol; 1993 Nov; 100(5):561-6. PubMed ID: 8249896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
    Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
    J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.
    Westermark P; Sletten K; Pitkänen P; Natvig JB; Lindholm CE
    Mol Immunol; 1982 Mar; 19(3):447-50. PubMed ID: 6808355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular primary cutaneous amyloidosis. Isolation and characterization of amyloid fibrils.
    Kitajima Y; Seno J; Aoki S; Tada S; Yaoita H
    Arch Dermatol; 1986 Dec; 122(12):1425-30. PubMed ID: 3789778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial amino acid sequence of an amyloid fibril protein from unusual cutaneous cystic lesions in myeloma-associated amyloidosis.
    Akiyama T; Seishima M; Nojiri M; Satoh M; Ichiki Y; Kitajima Y
    Eur J Dermatol; 1999 Dec; 9(8):624-8. PubMed ID: 10586130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloidosis related to a lambda IV immunoglobulin light chain protein.
    Benson MD; Dwulet FE; Madura D; Wheeler G
    Scand J Immunol; 1989 Feb; 29(2):175-9. PubMed ID: 2493677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid fibril protein related to immunoglobulin lambda-chains.
    Skinner M; Benson MD; Cohen AS
    J Immunol; 1975 Apr; 114(4):1433-5. PubMed ID: 804011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the amyloid fibril from primary localized cutaneous nodular amyloidosis associated with Sjögren's syndrome.
    Inazumi T; Hakuno M; Yamada H; Tanaka M; Naka W; Tajima S; Harada T; Nishikawa T
    Dermatology; 1994; 189(2):125-8. PubMed ID: 8075437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
    Olsen KE; Sandgren O; Sletten K; Westermark P
    Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR.
    Sletten K; Natvig JB; Husby G; Juul J
    Biochem J; 1981 Jun; 195(3):561-72. PubMed ID: 6797401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary localized cutaneous nodular amyloidosis: case report and biochemical analysis of amyloid.
    Konohana A; Teraki Y; Tajima S; Araki Y; Kitamura K; Nishikawa T
    Dermatologica; 1991; 183(2):114-9. PubMed ID: 1743371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain.
    Cohen D; Pras M; Franklin EC; Frangione B
    Am J Med; 1983 Mar; 74(3):513-8. PubMed ID: 6402931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
    Omtvedt LA; Husby G; Cornwell GG; Kyle RA; Sletten K
    Scand J Immunol; 1997 May; 45(5):551-6. PubMed ID: 9160102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein.
    Tveteraas T; Sletten K; Westermark P
    Biochem J; 1985 Nov; 232(1):183-90. PubMed ID: 3936482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid fibril protein of light chain type from the muscle in a patient with amyloidosis.
    Isobe T; Imura H; Miyazaki K
    Nihon Ketsueki Gakkai Zasshi; 1976 Jun; 39(3):329-30. PubMed ID: 824926
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
    Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
    Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.